🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

InRAD Observational Study

Recruitingn/aAges 18 Years - anyAllStichting International Registry for Alzheimer's …
NCT07213700 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine clinical practice across global clinical centers. The InRAD Registry Observational Study has several aims: * To collect medical information for many years from a large group of people with Alzheimer's disease. This will be used for research, which will support improved understanding about the disease. * To enable researchers to look at the effectiveness, usefulness and safety of treatments for Alzheimer's disease. * To enable researchers to answer similar research questions and compare results in many different areas of the world. People with Alzheimer's disease who meet the eligibility criteria and agree to participate in the Study will be asked to visit their doctor (e.g. psychiatrist,

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Be undergoing diagnostic work-up for Alzheimer's disease (AD), OR * Have a confirmed diagnosis of AD (whether currently treated with an AD-specific treatment, or untreated), * Be attending an InRAD Center, * Have provided informed consent for long-term follow-up Exclusion Criteria: -Any patient or legal representative who is unable or unwilling to provide a signed informed consent form The protocol does not specify a lower or upper age limit. Participants are expected to be predominantly adults, and can include younger adults with early-onset or genetically determined Alzheimer's disease (e.g. Down syndrome-associated Alzheimer's disease).
💊

What it tests

  • None, this is a non-interventional observational study
📍

Where

23 sites
Alfred Hospital
Melbourne, Australia
Medical University of Graz
Graz, Austria
Kardinal Schwarzenberg Klinikum
Schwarzach, Austria
UZLeuven
Leuven, Belgium
Irmandade da Santa Casa de São Paulo
São Paulo, Brazil
Motol and Homolka University Hospital (UHM)
Prague, Czechia
Ain Shams University
Cairo, Egypt
Aiginition Hospital
Athens, Greece

…and 15 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy